Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Anderson

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 30, 2008
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapyMarc A Rodger, Susan R Kahn, Philip S Wells, et al.
Thrombosis and Haemostasis|June 12, 2010
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort studyGrégoire Le Gal, Michael J Kovacs, Marc Carrier, et al.
Plos One|September 5, 2019
Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorphaDavid Wetzel, Jo-Anne Chan, Manfred Suckow, et al.
Eclinicalmedicine|July 9, 2020
Improving the coverage and accuracy of syphilis testing: The development of a novel rapid, point-of-care test for confirmatory testing of active syphilis infection and its early evaluation in China and South AfricaMinh D Pham, Amy Wise, Mary L Garcia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2015
An evaluation of a novel dual treponemal/nontreponemal point-of-care test for syphilis as a tool to distinguish active from past treated infectionLouise M Causer, John M Kaldor, Damian P Conway, et al.
British Journal of Haematology|April 27, 2011
Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolismMarc A Rodger, Natasha Kekre, Grégoire Le Gal, et al.
Nature Immunology|October 21, 2022
Mechanisms of CD40-dependent cDC1 licensing beyond costimulationRenee Wu, Ray A Ohara, Suin Jo, et al.
The Journal of Experimental Medicine|July 11, 2023
IL-6 selectively suppresses cDC1 specification via C/EBPβSunkyung Kim, Jing Chen, Suin Jo, et al.
Plos One|September 11, 2019
Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activityJo-Anne Chan, David Wetzel, Linda Reiling, et al.
Chemical Reviews|April 21, 2018
Parasites under the Spotlight: Applications of Vibrational Spectroscopy to Malaria ResearchDavid Perez-Guaita, Katarzyna M Marzec, Andrew Hudson, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 30, 2008
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapyMarc A Rodger, Susan R Kahn, Philip S Wells, et al.
Thrombosis and Haemostasis|June 12, 2010
Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort studyGrégoire Le Gal, Michael J Kovacs, Marc Carrier, et al.
Plos One|September 5, 2019
Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorphaDavid Wetzel, Jo-Anne Chan, Manfred Suckow, et al.
Eclinicalmedicine|July 9, 2020
Improving the coverage and accuracy of syphilis testing: The development of a novel rapid, point-of-care test for confirmatory testing of active syphilis infection and its early evaluation in China and South AfricaMinh D Pham, Amy Wise, Mary L Garcia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2015
An evaluation of a novel dual treponemal/nontreponemal point-of-care test for syphilis as a tool to distinguish active from past treated infectionLouise M Causer, John M Kaldor, Damian P Conway, et al.
British Journal of Haematology|April 27, 2011
Low prevalence of JAK2 V617F mutation in patients with first unprovoked venous thromboembolismMarc A Rodger, Natasha Kekre, Grégoire Le Gal, et al.
Nature Immunology|October 21, 2022
Mechanisms of CD40-dependent cDC1 licensing beyond costimulationRenee Wu, Ray A Ohara, Suin Jo, et al.
The Journal of Experimental Medicine|July 11, 2023
IL-6 selectively suppresses cDC1 specification via C/EBPβSunkyung Kim, Jing Chen, Suin Jo, et al.
Plos One|September 11, 2019
Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activityJo-Anne Chan, David Wetzel, Linda Reiling, et al.
Chemical Reviews|April 21, 2018
Parasites under the Spotlight: Applications of Vibrational Spectroscopy to Malaria ResearchDavid Perez-Guaita, Katarzyna M Marzec, Andrew Hudson, et al.
Pageof 7